Diagnosis and management of gonococcal infections

American Family Physician

Volumn 86, Issue 10, 2012, Pages 931-938

  Mayor, Mejebi T ^a,b   Roett, Michelle A ^c,d   Uduhiri, Kelechi A ^e  

^a Providence Hospital Washington DC   (United States)

^b HOWARD UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d Fort Lincoln Family Medicine Center   (United States)

^e Franklin Square Hospital Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; DOXYCYCLINE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANORECTAL DISEASE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL MENINGITIS; CHLAMYDIASIS; CONDOM USE; DRUG CONTRAINDICATION; FEMALE GENITAL TRACT INFECTION; FOLLOW UP; GONOCOCCAL CONJUNCTIVITIS; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT DISEASE; INFECTION RISK; MALE GENITAL TRACT INFECTION; MIXED INFECTION; PENICILLIN ALLERGY; PHARYNGITIS; SINGLE DRUG DOSE; UTERINE CERVICITIS; VAGINITIS; CONDOM; DIFFERENTIAL DIAGNOSIS; FEMALE; GENERAL PRACTICE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MICROBIOLOGY; PRACTICE GUIDELINE; REVIEW; UROGENITAL TRACT DISEASE; UTILIZATION REVIEW;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFTRIAXONE; CONDOMS; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, BACTERIAL; FAMILY PRACTICE; FEMALE; FEMALE UROGENITAL DISEASES; GONORRHEA; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MALE UROGENITAL DISEASES; PRACTICE GUIDELINES AS TOPIC;

EID: 84873515187     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010 [published correction appears in MMWR Recomm Rep. 2011;60(1):18]. MMWR Recomm Rep. 2010;59(RR-12):1-110.
2. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2010. Atlanta, Ga.: U.S. Department of Health and Human Services; 2011.
3. U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann Fam Med. 2005;3(3):263-267.
4. Hook EW III, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually Transmitted Diseases. 4th ed. New York, NY: McGraw-Hill; 2008.
5. Giannini CM, Kim HK, Mortensen J, Mortensen J, Marsolo K, Huppert J. Culture of non-genital sites increases the detection of gonorrhea in women. J Pediatr Adolesc Gynecol. 2010;23(4):246-252.
6. Ghanem KG. Gonorrhea. In: Bope ET, Kellerman R, Rakel RE, eds. Conn's Current Therapy 2011. Philadelphia, Pa.: Saunders/Elsevier; 2010.
7. Soper DE. Pelvic inflammatory disease. Obstet Gynecol. 2010;116(2 pt 1):419-428.
8. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis. 2006;193(3):336-345.
9. Ozgül A, Dede I, Taskaynatan MA, Aydogan H, Kalyon TA. Clinical presentations of chlamydial and non-chlamydial reactive arthritis. Rheumatol Int. 2006;26(10):879-885.
10. Bernstein KT, Stephens SC, Barry PM, et al. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clin Infect Dis. 2009;49(12):1793-1797.
11. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. 2007;44(suppl 3):S84-S101.
12. Haile Z, Khatua S. Beyond osteoarthritis: recognizing and treating infectious and other inflammatory arthropathies in your practice. Prim Care. 2010;37(4):713-727.
13. Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am. 2005;19(4):853-861.
14. Centers for Disease Control and Prevention (CDC). Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections. MMWR Morb Mortal Wkly Rep. 2012;61(31):590-594.
15. U.S. Preventive Services Task Force. Ocular prophylaxis for gonococcal ophthalmia neonatorum: reaffirmation recommendation statement. AHRQ publication no. 10-05146-2. July 2011. http://www.uspreventiveservicestaskforce.org/uspstf10/gonoculproph/gonocuprs.htm. Accessed January 17, 2012.
16. Blake DR, Duggan A, Quinn T, Zenilman J, Joffe A. Evaluation of vaginal infections in adolescent women: can it be done without a speculum? Pediatrics. 1998;102(4 pt 1):939-944.
17. Cook RL, Hutchison SL, Østergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005;142(11):914-925.
18. Roy K, Wang SA, Meltzer MI. Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae. Emerg Infect Dis. 2005;11(8):1265-1273.
19. Yates AB. Management of patients with a history of allergy to beta-lactam antibiotics. Am J Med. 2008;121(7):572-576.
20. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med. 2005;352(7):676-685.
21. Centers for Disease Control and Prevention. Expedited partner therapy. http://www.cdc.gov/std/ept. Accessed March 11, 2011.
22. Trelle S, Shang A, Nartey L, Cassell JA, Low N. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ. 2007;334(7589):354.
23. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis. 2009;36(8):478-489.
24. Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect. 2007;83(4):304-309.
25. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349(9069):1868-1873.
26. Lyss SB, Kamb ML, Peterman TA, et al.; Project RESPECT Study Group. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med. 2003;139(3):178-185.
27. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. 2007;147(2):89-96.
28. Gunn RA, O'Brien CJ, Lee MA, Gilchick RA. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997-2003. Sex Transm Dis. 2008;35(10):845-848.
29. Ness RB, Randall H, Richter HE, et al.; Pelvic Inflammatory Disease Evaluation and Clinical Health Study Investigators. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004;94(8):1327-1329.
30. Minnis AM, Padian NS. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm Infect. 2005;81(3):193-200.
31. U.S. Preventive Services Task Force. Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(7):491-496.
32. Lin JS, Whitlock E, O'Connor E, Bauer V. Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(7):497-508.
33. Shain RN, Piper JM, Newton ER, et al. A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med. 1999;340(2):93-100.